A common blood test may miss ovarian cancer in some Black and Native American patients, delaying their treatment, a new study finds. It's the latest example of medical tests that contribute to health ...

A new ovarian cancer surveillance test is now being offered to women with an inherited risk of the disease, marking a significant development in care. University College London Hospitals NHS ...

A common blood test may miss ovarian cancer in some racial groups Black and Native American women are more likely to get false negative results Experts say the test may need to be changed to help all ...

Premenopausal women would benefit from a significantly more accurate diagnostic pathway for ovarian cancer, as a new study finds that an advanced ultrasound test, IOTA ADNEX, identified 9 out of 10 ...

Landmark tumour mapping research could boost targeted breast and ovarian cancer therapies - The researchers said the findings ...

You might hear about your risk of ovarian cancer through an aunt, mother, sister or grandmother. For some, there are no signs of hereditary cancer in the family, but genetic testing still reveals a ...

The FDA has approved Lifyorli (relacorilant) plus Abraxane for certain platinum‑resistant ovarian cancer patients, offering a ...

A common test for ovarian cancer may be less effective on Black and Native American patients, new research has found. One of the two most common ways to test for ovarian cancer is to check for ...